A Novo Nordisk consultant wrote within an electronic mail that the drugmaker anticipates “ongoing offer disruption” for all those three doses as desire carries on to outpace generation. the organization did not have an estimate for how long they will continue to limit All those doses. We go on to construct capacity, buying new deal production